$750,000 Settlement

1월 26, 2017

This settlement was obtained on behalf of a client who suffered a nearly fatal cardiac arrest. The patient needed to be resuscitated but ultimately fell into a lengthy coma after being administered the general anesthesia bupivacaine. Anethesiologists knew the risk of administering this drug, yet still proceeded, putting the patient at an unnecessary risk.
Andexanet Alfa (Andexxa) Withdrawn from U.S. Market: What Patients Need to Know

by Christopher R. LoPalo, Partner AstraZeneca has withdrawn Andexxa (andexanet alfa) from the United States market effective December 22, 2025. Patients who experienced adverse health outcomes, complications, or...

Read the Article
PFAS in Biosolids: 2025 Statehouses Take the Lead

For PFAS in biosolids, 2025 was the year statehouses stepped decisively into the vacuum. While federal policy is evolving, state and local governments are rapidly redrawing the rules...

Read the Article
Suspected Birth Injury? What Parents Need to Know and Do Next

Bringing a baby into the world is supposed to be joyful. When something goes wrong during pregnancy, labor, or delivery, that joy can be replaced in an instant...

Read the Article
Contact Us:
Get a Free Case Evaluation Attorney Referral

Our Locations

Please Contact Us for an In-Person Appointment